These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24271138)

  • 21. TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status.
    Zhang L; Wang Y; Qin Z; Li R; Cong R; Ji C; Meng X; Wang Y; Xia J; Song N
    J Cancer; 2018; 9(19):3522-3531. PubMed ID: 30310509
    [No Abstract]   [Full Text] [Related]  

  • 22. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
    Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
    Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between the CYP1B1 Polymorphisms and Lung Cancer Risk: A Meta-Analysis.
    Chen PF; He XF; Huang GH; Wang W; Qiu ZH
    Technol Cancer Res Treat; 2016 Oct; 15(5):NP73-82. PubMed ID: 26283052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies.
    Dai S; Mao C; Jiang L; Wang G; Cheng H
    Hum Genet; 2009 Jun; 125(5-6):633-8. PubMed ID: 19357867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis.
    Hu Z; Li X; Qu X; He Y; Ring BZ; Song E; Su L
    Carcinogenesis; 2010 Apr; 31(4):643-7. PubMed ID: 20089604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of association of intron 3 16 bp polymorphism of TP53 with breast cancer among Iranian-Azeri patients.
    Pouladi N; Kouhsari SM; Feizi MH; Dehghan R; Azarfam P; Farajzadeh D
    Asian Pac J Cancer Prev; 2014; 15(6):2631-4. PubMed ID: 24761875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P53 codon 72 Arg/Pro polymorphism and lung cancer risk in Asians: an updated meta-analysis.
    Wang S; Lan X; Tan S; Wang S; Li Y
    Tumour Biol; 2013 Oct; 34(5):2511-20. PubMed ID: 23812725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controls.
    Zhuo W; Zhang L; Zhu B; Ling J; Chen Z
    PLoS One; 2012; 7(7):e41546. PubMed ID: 22844496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the p53 Arg72Pro polymorphism and its association with cancer risk: a HuGE review and meta-analysis.
    Khan MH; Khalil A; Rashid H
    Genet Res (Camb); 2015 Apr; 97():e7. PubMed ID: 25882871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the p53 codon 72 and intron 3 polymorphisms on non-small cell lung cancer (NSCLC) prognosis.
    Boldrini L; Gisfredi S; Ursino S; Lucchi M; Greco G; Mussi A; Donati V; Fontanini G
    Cancer Invest; 2008 Mar; 26(2):168-72. PubMed ID: 18259947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. XRCC1 codon 280 polymorphism and susceptibility to lung cancer: a meta-analysis of the literatures.
    Guo QX; Yang WH; Zhai JF; Han FC; Wang CY
    Tumour Biol; 2013 Oct; 34(5):2989-94. PubMed ID: 23733202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The codon 72 polymorphism of the TP53 gene and endometriosis risk: a meta-analysis.
    Feng Y; Wu YY; Li L; Luo ZJ; Lin Z; Zhou YH; Yi T; Lin XJ; Zhao QY; Zhao X
    Reprod Biomed Online; 2015 Sep; 31(3):320-6. PubMed ID: 26194887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TP53 Arg72Pro polymorphism and lung cancer risk: a meta-analysis.
    Yan L; Zhang D; Chen C; Mao Y; Xie Y; Li Y; Huang Y; Han B
    Int J Cancer; 2009 Dec; 125(12):2903-11. PubMed ID: 19623649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk.
    Lv L; Wang P; Zhou X; Sun B
    Tumour Biol; 2013 Jun; 34(3):1451-9. PubMed ID: 23564481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
    Nairuz T; Rahman M; Bushra MU; Kabir Y
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.
    Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X
    Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between the XRCC3 polymorphisms and breast cancer risk: meta-analysis based on case-control studies.
    He XF; Wei W; Su J; Yang ZX; Liu Y; Zhang Y; Ding DP; Wang W
    Mol Biol Rep; 2012 May; 39(5):5125-34. PubMed ID: 22161248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis.
    Zeng XT; Luo W; Geng PL; Guo Y; Niu YM; Leng WD
    BMC Cancer; 2014 Jun; 14():469. PubMed ID: 24969046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.
    Peng Q; Lao X; Chen Z; Lai H; Deng Y; Wang J; Mo C; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
    PLoS One; 2013; 8(12):e82773. PubMed ID: 24376578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of TP53 intron 3, 16 bp duplication polymorphism with esophageal and gastric cancer susceptibility in Kashmir Valley.
    Malik MA; Sharma K; Goel S; Zargar SA; Mittal B
    Oncol Res; 2011; 19(3-4):165-9. PubMed ID: 21473292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.